According to a Comprehensive Research Report by Market Research Future (MRFR), “Neuropathic Pain Market Information by Type, Indication, Diagnosis, Treatment, Distribution Channel, End user and Region– Forecast till 2030” the market size was prized at USD 2.4 billion in 2021. The neuropathic pain industry is projected to grow from USD 2.6 Billion in 2022 to USD 4.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.72% during the forecast period (2022 – 2030)

Injury to the tissues is often the trigger for neuropathic pain, a complex and chronic pain state. Injuries to the nervous system can cause pain signal miscommunication between different brain regions. When a nerve fiber is damaged, it affects more than just the area directly around the injury.

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/1390

Report Scope:

Report AttributeDetails
Market Size in 2030USD 4.9 Billion
CAGR4.72%
Base Year2021
Forecast Period2022-2030
Historical Data2020
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredBy Type, Indication, Diagnosis, Treatment and End-User
Geographies CoveredNorth America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market DriversRising cases of diabetics to boost the market growth
Increase in the geriatric population is predicted to increase the demand for neuropathic pain management services

Competitive Dynamics:

There are a number of promising expansion avenues in the Neuropathic Pain Market that businesses operating in this sector can pursue. Experts believe that R&D will contribute to the expansion of the Market. The major companies in the market are investing heavily in clinical trials, new pain relief medications, and technological advancements.

Here is the list of some companies-

  • Sanofi
  • Abbott
  • Astellas
  • Pfizer
  • Eli Lily
  • Johnson and Johnson
  • AstraZeneca
  • GSK

Neuropathic Pain Market Dynamics:

Market Drivers

One of the most important things driving the market is the sheer number of people in the world. The market will also be helped along by factors such as increased demand for solutions to neuropathic pain, advancements in treatment and healthcare infrastructure, increased investment from pharmaceutical companies, and advancements in drug quality and the availability of pain management systems.

It is anticipated that research into neuropathic pain would also contribute to the expansion of the industry. An aqueous ethanol extract of Haematoxylon campechianum flowers was studied for its potential preventative benefits on peripheral neuropathic pain in a chronic constriction injury rat model by scientists at Heidelberg University in Germany in March 2020.

Market Limitations The Neuropathic Pain Market reports that unsatisfactory pain relief and medication side effects are two potential market restraints that could slow the market’s expansion. Solid opioids like oxycodone, used to treat neuropathic pain, reduce discomfort, but only slightly.

Market expansion for neuropathic pain is anticipated to be slowed by incomplete pain alleviation. When treating neuropathic pain, for instance, powerful opiates like oxycodone are generally ineffective.

Browse In-depth Market Research Report (208 Pages) on Neuropathic Pain: https://www.marketresearchfuture.com/reports/neuropathic-pain-market-1390

COVID-19 Analysis:

As a result of the COVID-19 pandemic, the market for treatments for neuropathic pain was disrupted in significant ways around the world. Any viral infection can have a profound effect on the nervous system; therefore the patients were especially vulnerable due to the outbreak.

Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=1390

Market Segmentation:

The Neuropathic Pain Market is segmented into these categories-

By Indication

Chemotherapy-induced Peripheral neuropathy is poised to expand at a notable CAGR.

By Type

Painful Diabetic Peripheral Neuropathy to record substantial growth over the review period.

By Diagnosis

Imaging MRI segment is dominating the market over the forecast period.

By Treatment

Medication segment is expected to rise at a substantial CAGR over the review period.

By End-users

Hospitals segment is poised to grow significantly over the review period.

Share your Queries @ https://www.marketresearchfuture.com/enquiry/1390

Neuropathic Pain Market Regional Analysis:

In 2019, the combined market value of the countries of North America and South America was $6,645.09 million. It is expected to grow at a CAGR of about 5.6% during the forecast horizon. The primary reasons driving the growth of the Neuropathic Pain Market are the increasing prevalence of neuropathic pain-related illnesses, advances in technology, and more public awareness. The United States has been responsible for the lion’s share of the North American market. Increased expenditures in the country for the adoption of cutting-edge technologies, as well as the existence of major market players and sizable pharmaceutical and biopharmaceutical industries, are all factors that should contribute to the region’s growth in the market over the projection period.

Discover more research Reports on Healthcare Industry by Market Research Future:

Global Diabetic Neuropathy Treatment Market Research Report: By Disorder (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy), By Treatment (Drugs, TENS, Others) and By End-User (Hospitals and Clinics, Retail Pharmacy, Online Pharmacy, Others) – Forecast to 2030

Peripheral Neuropathy Market Research Report: By Type (Diabetic Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, HIV/AIDS Associated Peripheral Neuropathy), Treatment (Pharmacological Therapies, Non-Pharmacological Therapies, Others) and End-User (Hospitals and Clinics, Ambulatory Centers, Others) – Forecast to 2030

Pain Management Devices Market Research Report, Type (stimulators, transcutaneous Electrical Nerve Stimulation Devices, Pumps, Ablation Devices), Application (Cancer Pain, Musculoskeletal Pain, Migraine and Other) – Forecast Till 2030

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter

 

Neuropathic Pain Market Size Worth USD 4.9 Billion by 2030 at 4.72% CAGR – Report by Market Research Future (MRFR)